Table S5. Univariate and multivariate Cox regression analyses in low-risk group of non-G-CIMP (or HSPB2 hypermethylated IDH1R132H wt) GBMs. (XLSX 23 kb
Table S1. Title: 104 common survival-related genes were identified from patients with GBM and those ...
Table S1. Twenty GBM patients and treatment characteristic. Table S2. Primers for qRT-PCR and siRNA ...
The differential expressive genes between U87 and U251 glioma cell lines. (A) Heatmap showed the dif...
Table S6. Univariate and multivariate Cox regression analyses in high-risk group of non-G-CIMP (or H...
Table S4. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with R...
Figure S2. The molecular correlation of each CpGs with genome DNA methylation status in GBMs; (A) th...
Figure S1. The diagram of patient selection in each cohort; (A) selection of non-G-CIMP GBMs with RT...
Figure S7. The prognostic performance of the GBM-derived epigenetic signature in a RT/TMZ cohort of ...
Figure S4. The predictive performance in terms of PFS outcome; (A) interaction analysis between trea...
Figure S3. The prognostic performance in terms of PFS outcome; (A) patient classification by the RIS...
Figure S5. The patient classification in cohorts stratified by MGMT promoter methylation status and ...
Figure S6. The clinical performance of the RISK-score signature in combination with conventional ris...
Table S2. Univariate and Multivariate Models for Overall Survival in Patients with GBM in the TCGA C...
Figure S5. (a) Kaplan-Meier OS curves for patients in the TMZ group after classifying patients into ...
Additional file 4: Fig. S4. Validation of independence of our risk score as a prognostic factor. A T...
Table S1. Title: 104 common survival-related genes were identified from patients with GBM and those ...
Table S1. Twenty GBM patients and treatment characteristic. Table S2. Primers for qRT-PCR and siRNA ...
The differential expressive genes between U87 and U251 glioma cell lines. (A) Heatmap showed the dif...
Table S6. Univariate and multivariate Cox regression analyses in high-risk group of non-G-CIMP (or H...
Table S4. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with R...
Figure S2. The molecular correlation of each CpGs with genome DNA methylation status in GBMs; (A) th...
Figure S1. The diagram of patient selection in each cohort; (A) selection of non-G-CIMP GBMs with RT...
Figure S7. The prognostic performance of the GBM-derived epigenetic signature in a RT/TMZ cohort of ...
Figure S4. The predictive performance in terms of PFS outcome; (A) interaction analysis between trea...
Figure S3. The prognostic performance in terms of PFS outcome; (A) patient classification by the RIS...
Figure S5. The patient classification in cohorts stratified by MGMT promoter methylation status and ...
Figure S6. The clinical performance of the RISK-score signature in combination with conventional ris...
Table S2. Univariate and Multivariate Models for Overall Survival in Patients with GBM in the TCGA C...
Figure S5. (a) Kaplan-Meier OS curves for patients in the TMZ group after classifying patients into ...
Additional file 4: Fig. S4. Validation of independence of our risk score as a prognostic factor. A T...
Table S1. Title: 104 common survival-related genes were identified from patients with GBM and those ...
Table S1. Twenty GBM patients and treatment characteristic. Table S2. Primers for qRT-PCR and siRNA ...
The differential expressive genes between U87 and U251 glioma cell lines. (A) Heatmap showed the dif...